• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAGELLAN DIAGNOSTICS, INC. LEADCARE II BLOOD LEAD TEST SYSTEM; LEADCARE II ANALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAGELLAN DIAGNOSTICS, INC. LEADCARE II BLOOD LEAD TEST SYSTEM; LEADCARE II ANALYZER Back to Search Results
Model Number 70-6529-P
Device Problems Imprecision (1307); Calibration Problem (2890)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/17/2018
Event Type  malfunction  
Manufacturer Narrative
1218996-2018-00040 addendum.Customer called indicating their leadcare ii capillary results inconsistent with venous reference results.These results were collected over a year time period, and traceability to the lots used during testing are not available for investigative evaluation.The unit was returned for testing after the original mdr [1218996-2018-00040] was submitted on 17nov2018.Testing performed: test 2 sets of whole blood patient samples in duplicates on both returned analyzer wlc09319 and in house analyzer wlc00105 against gfaas results.Conclusion: all qc and whole blood samples tested on both the in-house analyzer and returned analyzer generated results that correlated well with gfaas no reported harm or injuries occurred as a result of this issue.Customer coplaint: (b)(6).After further investigation it has been confirmed that none of the blood lead sample results are considered reportable events.Data below: sample 1: leadcare ii 7.1ug/dl vs labcorp: 10 ug/dl, not reportable, sample 2: leadcare ii 5.1 ug/dl vs labcorp: 11 ug/dl, not reportable, sample 3: leadcare ii: 8.5 ug/dlvs labcorp: 11 ug/dl, not reportable, sample 4: leadcare ii: 9.5 ug/dl vs labcorp: 13 ug/dl.Not reportable.
 
Event Description
1218996-2018-00040 addendum.Customer called requesting information on correlation to reference laboratories on (b)(6) 2018.After further verbal discussion the customer provided data on (b)(6) 2018 indicating erroneous patient results over the course of a year.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LEADCARE II BLOOD LEAD TEST SYSTEM
Type of Device
LEADCARE II ANALYZER
Manufacturer (Section D)
MAGELLAN DIAGNOSTICS, INC.
101 billerica ave
building 4
n. billerica MA 01862
Manufacturer (Section G)
MAGELLAN DIAGNOSTICS, INC.
101 billerica ave.
building 4
n. billerica MA 01862
Manufacturer Contact
ivy margaret thiong'o
101 billerica ave.
building 4
n. billerica, MA 01862
9783135480
MDR Report Key9150897
MDR Text Key220250803
Report Number1218996-2019-00019
Device Sequence Number1
Product Code DOF
UDI-Device Identifier00850355006017
UDI-Public00850355006017
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K052549
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/03/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number70-6529-P
Device Catalogue Number70-6529-P
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/29/2018
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/17/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/01/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
-
-